lipo c injection vs semaglutide Wegovy: Injectable Weight Loss Compared Understanding the differences between fat-dissolving

In: Post TW, ed

Participants were adults aged 18-75 years with a BMI 30 or 27.5 kg/m 2 with the presence of obesity-related comorbidities who initiated a weight management program involving semaglutide or tirzepatide

Wegovy is given as a once-a-week injection, starting at a low dose and gradually increasing to the maintenance dose of 2.4 mg over 16 weeks

Some are mild, while others can be intense

Slower weight loss can still be healthy and effective

According to the European Medicines Agency's assessment, these rodent findings are of uncertain clinical relevance to humans, and unlike in the US, there is no contraindication for patients with a history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 in the UK and EU prescribing information